脑出血与蛛网膜下腔出血后的血压管理:已知与未知
本文聚焦脑出血和动脉瘤性蛛网膜下腔出血急性期的血压管理,指出脑出血降压时机、机制和方法仍存争议,蛛网膜下腔出血则需权衡降压防再出血与升压防迟发性脑缺血,并综述血流动力学、脑自动调节与灌注证据以形成推荐。
要点
- 脑出血急性期降压的潜在获益已有共识,但时机、机制和方法仍存争议。
- 蛛网膜下腔出血血压管理更复杂,降压防再出血与升压防迟发性脑缺血各有依据。
- 通过临床试验个体患者数据Meta分析可明确血压变化与关键结局的强度和方向。
核心结论
- 本聚焦更新概述了脑出血和蛛网膜下腔出血后血压管理的当前证据、知识空白及全身血流动力学、脑自动调节与灌注的新兴概念,以促进临床实践推荐和未来研究。
研究设计与样本
- 本文为聚焦更新(综述),未报告系统检索范围与样本量。
主要发现
- 脑出血急性期降压的潜在获益已有共识,但时机、机制和方法仍存争议。
- 蛛网膜下腔出血的血压控制更复杂,降压以降低再出血风险与升压以降低迟发性脑缺血风险各有依据。
- 通过Meta分析详细探索临床试验个体患者数据,可确定脑出血中血压变化与关键结局关联的强度和方向,并可能同样适用于蛛网膜下腔出血。
- 大量血流动力学数据为血压与脑血流的病理生理相互关系提供了见解。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Blood pressure (BP) elevations often complicate the management of intracerebral hemorrhage and aneurysmal subarachnoid hemorrhage, the most serious forms of acute stroke. Despite consensus on potential benefits of BP lowering in the acute phase of intracerebral hemorrhage, controversies persist over the timing, mechanisms, and approaches to treatment. BP control is even more complex for subarachnoid hemorrhage, where there are rationales for both BP lowering and elevation in reducing the risks of rebleeding and delayed cerebral ischemia, respectively. Efforts to disentangle the evidence has involved detailed exploration of individual patient data from clinical trials through meta-analysis to determine strength and direction of BP change in relation to key outcomes in intracerebral hemorrhage, and which likely also apply to subarachnoid hemorrhage. A wealth of hemodynamic data provides insights into pathophysiological interrelationships of BP and cerebral blood flow. This focused update provides an overview of current evidence, knowledge gaps, and emerging concepts on systemic hemodynamics, cerebral autoregulation and perfusion, to facilitate clinical practice recommendations and future research.
引用
- Minhas JS, Moullaali TJ, Rinkel GJE, et al. Blood Pressure Management After Intracerebral and Subarachnoid Hemorrhage: The Knowns and Known Unknowns. Stroke. 2022. PMID: 35255708. doi:10.1161/STROKEAHA.121.036139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。